Total Payments
$734,576
2024 Payments
$43,301
Companies
15
Transactions
958
Payment Breakdown by Category
Other$613,275 (83.5%)
Travel$95,103 (12.9%)
Consulting$14,418 (2.0%)
Food & Beverage$11,659 (1.6%)
Education$121.61 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $613,275 | 274 | 83.5% |
| Travel and Lodging | $95,103 | 412 | 12.9% |
| Consulting Fee | $14,418 | 5 | 2.0% |
| Food and Beverage | $11,659 | 257 | 1.6% |
| Education | $121.61 | 10 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $303,835 | 304 | $0 (2024) |
| Allergan, Inc. | $261,945 | 405 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $44,826 | 49 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $41,239 | 45 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $37,894 | 52 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $15,953 | 29 | $0 (2017) |
| Alkermes, Inc. | $14,617 | 25 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $8,676 | 14 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $4,690 | 14 | $0 (2020) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $296.50 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43,301 | 47 | ABBVIE INC. ($43,301) |
| 2023 | $137,101 | 126 | ABBVIE INC. ($137,071) |
| 2022 | $74,493 | 79 | ABBVIE INC. ($66,531) |
| 2021 | $68,184 | 93 | AbbVie Inc. ($56,932) |
| 2020 | $67,828 | 86 | Allergan, Inc. ($67,073) |
| 2019 | $104,178 | 151 | Allergan Inc. ($86,171) |
| 2018 | $135,557 | 211 | Allergan Inc. ($75,003) |
| 2017 | $103,934 | 165 | Takeda Pharmaceuticals America, Inc. ($44,826) |
All Payment Transactions
958 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $54.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $7.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $298.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $236.96 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $208.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $236.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $176.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.42 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $93.09 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $68.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $723.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Noel Gardner, MD
Dr. Noel Gardner, MD is a Psychiatry healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285655746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Noel Gardner, MD has received a total of $734,576 in payments from pharmaceutical and medical device companies, with $43,301 received in 2024. These payments were reported across 958 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($613,275).
Ad
Practice Information
- Specialty Psychiatry
- Location Salt Lake City, UT
- Active Since 07/21/2006
- Last Updated 01/29/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285655746
Products in Payments
- VRAYLAR (Drug) $565,770
- Trintellix (Drug) $84,499
- LATUDA (Drug) $37,845
- BELSOMRA (Drug) $15,953
- LYBALVI (Drug) $14,365
- NUPLAZID (Drug) $8,676
- TRINTELLIX (Drug) $1,566
- REXULTI (Drug) $242.79
- CAPLYTA (Drug) $213.56
- ARISTADA (Drug) $161.51
- SPRAVATO (Drug) $117.55
- Aristada 441 mg (Drug) $90.37
- ABILIFY MAINTENA (Drug) $41.02
- INGREZZA (Drug) $24.28
- ABILIFY MYCITE (Drug) $19.72
- INVEGA SUSTENNA (Drug) $14.24
- VIIBRYD (Drug) $10.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Salt Lake City
Dr. Clark Johnson, M.d, M.D
Psychiatry — Payments: $8,896
Psychiatry $8,896
Dr. Mark Neuman, Md, MD
Psychiatry — Payments: $2,188
Psychiatry $2,188
Julian Thorne, Md, MD
Psychiatry — Payments: $2,152
Psychiatry $2,152
Mithu Chaudhury, Do, DO
Psychiatry — Payments: $1,229
Psychiatry $1,229
Marc Davis, Md, MD
Psychiatry — Payments: $910.49
Psychiatry $910.49
Dr. Sajid Faizi, M.d, M.D
Psychiatry — Payments: $882.96
Psychiatry $882.96